128 related articles for article (PubMed ID: 6969688)
1. "Self-reactive" T cells. I. In vivo reaction of T cells to transferred polyclonally activated syngeneic and autologous lymphoblasts.
Reimann J; Diamantstein T
Immunobiology; 1980 Dec; 157(4-5):437-49. PubMed ID: 6969688
[TBL] [Abstract][Full Text] [Related]
2. "Self-reactive" T cells. III. In vitro restimulation of T cells, "responding" in vivo or in vitro to syngeneic lymphoid cells.
Reimann J; Diamantstein T
Immunobiology; 1980 Dec; 157(4-5):463-73. PubMed ID: 6450160
[TBL] [Abstract][Full Text] [Related]
3. "Self-reactive" T cells. II. Transferred syngeneic lymphoblasts induce T "stimulator" cells in vivo, to which syngeneic T cells "respond" in a syngeneic MLC in vitro.
Reimann J; Diamantstein T
Immunobiology; 1980 Dec; 157(4-5):450-62. PubMed ID: 6450159
[TBL] [Abstract][Full Text] [Related]
4. Self-reactive T cells. V. T cell-mediated suppression of B cell responsiveness to LPS.
Reimann J; Diamantstein T
Immunobiology; 1981; 159(3):228-34. PubMed ID: 6973538
[TBL] [Abstract][Full Text] [Related]
5. Self-reactive T cells. IV. Self-reactive T cells induce polyclonal differentiation of IgM-producing B cells in vivo and in vitro.
Reimann J; Diamantstein T
Immunobiology; 1981; 159(3):215-27. PubMed ID: 6973537
[TBL] [Abstract][Full Text] [Related]
6. Lymphoblastogenesis stimulates proliferation of interacting Lyt1 T cells in a syngeneic system.
Reimann J; Kaufmann SH; Diamantstein T
Eur J Immunol; 1981 Aug; 11(8):604-7. PubMed ID: 6456148
[TBL] [Abstract][Full Text] [Related]
7. Induction or suppression of B cell proliferation and differentiation by phytohemagglutinin or concanavalin A in mouse spleen cell cultures.
Piguet PF; Dewey HK; Vassalli P
J Immunol; 1976 Nov; 117(5 Pt.2):1817-23. PubMed ID: 1086865
[TBL] [Abstract][Full Text] [Related]
8. In vivo regulation of the cytolytic T cell response to hapten-altered self: suppressor T cells induced in the regional lymph nodes by exposure to syngeneic spleen cells.
Wong HL; Battisto JR
Eur J Immunol; 1984 Jul; 14(7):629-33. PubMed ID: 6235115
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of NK cell activation: relationship between Qa5+ NK cells and lymphocytes.
Chun M; Fernandes G; Hoffmann MK
J Immunol; 1981 Jan; 126(1):331-4. PubMed ID: 7451974
[TBL] [Abstract][Full Text] [Related]
10. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
11. Syngeneic mixed lymphocyte reaction in mice: strain distribution, kinetics, participating cells, and absence in NZB mice.
Smith JB; Pasternak RD
J Immunol; 1978 Nov; 121(5):1889-92. PubMed ID: 152331
[TBL] [Abstract][Full Text] [Related]
12. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
13. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
Good MF; Nossal GJ
J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
[TBL] [Abstract][Full Text] [Related]
14. Activation requirements of cloned inducer T cells. I. Differential inhibition by anti-L3T4 or anti-I-A is determined by the accessory cell population.
DeKruyff R; Clayberger C; Cantor H; Dorf ME
J Immunol; 1985 Oct; 135(4):2243-8. PubMed ID: 3897372
[TBL] [Abstract][Full Text] [Related]
15. Cloned auto-Ia-reactive T cells elicit lichen planus-like lesion in the skin of syngeneic mice.
Saito K; Tamura A; Narimatsu H; Tadakuma T; Nagashima M
J Immunol; 1986 Oct; 137(8):2485-95. PubMed ID: 2944957
[TBL] [Abstract][Full Text] [Related]
16. Differences between normal and autoimmune T cell responses to autologous erythrocytes and haemoglobin: impairment of haptoglobin-mediated inhibition in NZB spleen cells.
Calkins CE; Esposito M
J Autoimmun; 1996 Aug; 9(4):453-62. PubMed ID: 8864820
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
McMaster R; Levy JG
J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
Ryan JJ; Mond JJ; Finkelman FD; Scher I
J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
[TBL] [Abstract][Full Text] [Related]
19. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
20. In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor.
Gautam SC; Hilfiker ML; Battisto JR
J Immunol; 1983 Feb; 130(2):533-7. PubMed ID: 6217243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
